tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRBU Stock Latest News

Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
Market NewsHere is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
1d ago
BIB
CRBU
Caribou Biosciences initiated with a Buy at Clear Street
PremiumThe Fly
Caribou Biosciences initiated with a Buy at Clear Street
18d ago
CRBU
Caribou Biosciences price target lowered to $6 from $8 at BofA
PremiumThe Fly
Caribou Biosciences price target lowered to $6 from $8 at BofA
2M ago
CRBU
Caribou Biosciences: Promising Financials and Clinical Success Drive Buy Rating
PremiumRatings
Caribou Biosciences: Promising Financials and Clinical Success Drive Buy Rating
3M ago
CRBU
Caribou Biosciences Reports Increased Losses Amid R&D Focus
PremiumCompany Announcements
Caribou Biosciences Reports Increased Losses Amid R&D Focus
3M ago
CRBU
Caribou Biosciences reports Q3 EPS (30c) vs. (38c) last year
PremiumThe FlyCaribou Biosciences reports Q3 EPS (30c) vs. (38c) last year
3M ago
CRBU
FDA appoints Richard Pazdur as Director of CDER
Premium
The Fly
FDA appoints Richard Pazdur as Director of CDER
3M ago
AZN
BMY
Is CRBU a Buy, Before Earnings?
Premium
Pre-Earnings
Is CRBU a Buy, Before Earnings?
3M ago
CRBU
Caribou Biosciences price target raised to $9 from $3 at H.C. Wainwright
PremiumThe Fly
Caribou Biosciences price target raised to $9 from $3 at H.C. Wainwright
4M ago
CRBU
3 Penny Stocks to Watch Now, 11/4/25
PremiumMarket News
3 Penny Stocks to Watch Now, 11/4/25
4M ago
HKD
TGE
Caribou Biosciences price target raised to $8 from $5 at Citi
PremiumThe Fly
Caribou Biosciences price target raised to $8 from $5 at Citi
4M ago
CRBU
Caribou Biosciences Reports Positive ANTLER Phase 1 Results
PremiumCompany Announcements
Caribou Biosciences Reports Positive ANTLER Phase 1 Results
4M ago
8K
CRBU
Caribou Biosciences announces results from CaMMouflage Phase 1 trial
PremiumThe FlyCaribou Biosciences announces results from CaMMouflage Phase 1 trial
4M ago
CRBU
Caribou Biosciences announces results from ANTLER phase 1 trial of vispa-cel
Premium
The Fly
Caribou Biosciences announces results from ANTLER phase 1 trial of vispa-cel
4M ago
CRBU
Caribou Biosciences’ CRISPR-Edited CAR-T Therapy: A Promising Step in Multiple Myeloma Treatment
Premium
Company Announcements
Caribou Biosciences’ CRISPR-Edited CAR-T Therapy: A Promising Step in Multiple Myeloma Treatment
4M ago
CRBU
Caribou Biosciences’ Long-Term Study: A Key Update for Investors
PremiumCompany Announcements
Caribou Biosciences’ Long-Term Study: A Key Update for Investors
4M ago
CRBU
Video: This stock is dragging down the in vivo gene editing therapy space
PremiumThe Fly
Video: This stock is dragging down the in vivo gene editing therapy space
4M ago
MGX
BEAM
Caribou Biosciences Advances CRISPR-Edited CAR-T Therapy in Lymphoma Study
PremiumCompany Announcements
Caribou Biosciences Advances CRISPR-Edited CAR-T Therapy in Lymphoma Study
4M ago
CRBU
Intellia Therapeutics price target lowered to $30 from $36 at BofA
PremiumThe Fly
Intellia Therapeutics price target lowered to $30 from $36 at BofA
4M ago
BEAM
CRBU
Caribou Biosciences: Promising HLA Data and Trial Results Reinforce Buy Rating
PremiumRatingsCaribou Biosciences: Promising HLA Data and Trial Results Reinforce Buy Rating
5M ago
CRBU
Caribou Biosciences: Promising Clinical Progress and Strong Financial Position Justify Buy Rating
Premium
Ratings
Caribou Biosciences: Promising Clinical Progress and Strong Financial Position Justify Buy Rating
6M ago
CRBU
Caribou Biosciences Reports Increased Losses Amid R&D Efforts
Premium
Company Announcements
Caribou Biosciences Reports Increased Losses Amid R&D Efforts
6M ago
CRBU

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >